• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » EXCLUSIVE: Palmaz Scientific, out of cash, taps ex-KCI CEO Burzik

EXCLUSIVE: Palmaz Scientific, out of cash, taps ex-KCI CEO Burzik

August 17, 2015 By Brad Perriello

Palmaz Scientific

UPDATED August 17, 2015, 5 p.m., with comment from Julio Palmaz.

Palmaz Scientific, the company co-founded by coronary stent pioneer Dr. Julio Palmaz in 2008, is out of cash and looking for a new CEO, according to a letter to shareholders obtained by MassDevice.com.

Julio Palmaz plans to step down from his chairman’s role at Palmaz Scientific, to be replaced by former Kinetic Concepts Inc. CEO Cathy Burzik. Burzik, who led KCI through its $6.1 billion sale to a private equity consortium in 2011, will also serve as interim CEO as Palmaz Scientific seeks a replacement for Steven Solomon. He resigned “to pursue other opportunities,” according to the letter. Julio Palmaz will stay on as chief scientific officer, he wrote in the August 13 letter.

Palmaz Scientific has “completely exhausted its financial resources” and faces mounting debts with no money coming in, despite a recent infusion of several million dollars from the Palmaz family, according to the letter. After seeking and failing to find traction with larger medical device companies for the new medical alloy its developing, Julio Palmaz wrote, the Fremont, Calif.-based company is seeking an infusion from a group of investors led by venture capital shop Targeted Technology, where Burzik is an operating partner.

Burzik today confirmed to MassDevice.com that the letter was sent to shareholders last week, but declined to elaborate.

Palmaz Scientific raised $26.3 million from some 260 private investors in November 2013, but a hoped-for debt offering worth $15 million in the spring failed to bring in any outside backers despite the $2 million put down by members of the board. An outside investment firm also failed to gin up any interest, according to the shareholders letter.

The company’s technology involves laser etching of high-performance “super-alloys” the company believes can disrupt several markets, Palmaz wrote.

“We believe if we can bring to regulatory approval in the United States just one of the half a dozen devices we could create today, it could be a game-changer. For example, we believe that we can create devices which will be superior to anything in the market today to treat peripheral artery disease, intra-cranial aneurysms, and structural heart disease, all of which have significant unmet medical needs for both clinicians and patients,” he wrote.

“Our efforts to partner with large medical device manufacturers have encountered a consistent negative attitude by their R&D teams. The nature of our fabrication methods imply a profound restructuring of the conventional methodology, as is currently used by all medical device manufacturers. Our advanced fabrication methods have been highly resisted by all companies we have approached to partner with, typically rationalizing their aversion to change,” Palmaz wrote. “Therefore, I believe that we should take the offensive – designing, testing and producing our own devices – we believe we can break through the prevailing conservatism of the major medical device manufacturers and create an opportunity to compete on an even playing field.”

Palmaz Scientific should focus on “taking a new-generation intravascular stent all the way to U.S. and international market approval,” he recommended.

Julio Palmaz told MassDevice.com during a telephone interview that PSI is focused on creating a new super-alloy for smaller medical devices.

“During the years that I have worked on this, 1st in the lab and then in the clinical realm, I always thought there was a void in what a stent could be, in so far as materials,” he told us. “We can actually make better intravascular stents [for the]  intracranial space and small vessels below the knee. Those 2 areas really stress the need for advanced materials.”

Palmaz said the metal alloys used to make devices like coronary stents are “crude and full of impurities”  that make them inadequate for smaller, micro-sized devices like below-the-knee stents.

“It’s a material that works well in the larger sizes, but the minute you get down to the smaller devices, they start failing. The metal at that point cannot be made with the conventional natural alloys,” he said, explaining that the PSI metal is a high-purity alloy designed to deliver the structural integrity and predictability needed at that smaller scale.

“The structure is essentially very ordered. That allows the mechanical properties to be optimized at very small sizes,” Palmaz said, noting that an intracranial stent would need to be no more than 50µ to 60µ thick.

Palmaz estimated that it would take $20 million to $25 million to get an intravascular stent on the U.S. market and slightly less than that for an intracranial stent.

“Palmaz Scientific is very well positioned to do this,” he told us. “I’m very confident that our technology is superior and, given the opportunity, we should succeed.”

Filed Under: Cardiovascular, Funding Roundup, Stents Tagged With: Palmaz Scientific, Personnel Moves

In case you missed it

  • RefleXion closes $125M debt facility
  • Senseonics announces equity grants to employees
  • New data backs Aerin’s RhinAer for treating chronic rhinitis
  • Enovis completes Insight Medical acquisition
  • Orchestra BioMed to go public, partner with Medtronic on cardiac neuromodulation therapy
  • Memic Innovative Surgery is now Momentis Surgical
  • Lyra Therapeutics appoints new chief medical officer
  • Masimo’s SafetyNet monitoring reduced length of COVID-19 hospital stays, study says
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • Enovis partners with Kelvi on hot and cold therapies
  • West Pharmaceutical Services debuts new needle syringe system
  • Titan Medical names Cary G. Vance as new president, CEO
  • Acutus completes first closing in left-heart access portfolio sale to Medtronic
  • FDA clears Intuitive, Siemens Healthineers imaging integration for robotic bronchoscopy
  • FDA backs COVID-19 boosters with BA.4/5 spike proteins for fall
  • How safe is health information after the overturning of Roe?

RSS From Medical Design & Outsourcing

  • DeviceTalks Boston 2022: Here’s what you missed on the show floor
    At DeviceTalks Boston 2022, there was a wealth of expertise to be had from exhibitors including Viant, ICS, PSN Labs, Propel and more. From stories of overcoming challenges during the COVID-19 pandemic to medical device materials pitfalls to avoid, MassDevice and MDO executive editor Chris Newmarker hit the DeviceTalks Boston show floor to discover insights. […]
  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS